GlassScriptPhysician profile
Lynn M Westphal
NPI 1134269723
$1,289.90
in general payments reported to CMS, 2019-2025
11 companies · $295 in 2025
The $295 reported for 2025 was more than what 76% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.76 · 2020: $100 · 2021: $105 · 2022: $277 · 2023: $289 · 2024: $205 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $790.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $789.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $643.49 | 2020-2025 | |
| Ferring Pharmaceuticals INC. | $231.44 | 2020-2025 | Menopur |
| Organon LLC | $171.09 | 2021-2025 | Follistim Aq, Ganirelix Acetate |
| Merck Sharp & Dohme LLC | $76.78 | 2019-2021 | |
| Coopersurgical, INC. | $63.48 | 2025 | Origio Sequential Fert |
| Myovant Sciences INC. | $24.62 | 2022 | |
| Abbvie INC. | $21.40 | 2022 | |
| Hologic Sales and Service, LLC | $21.27 | 2023 | Myosure Tissue Removal Device, Novasure |
| Medtronic, INC. | $20.29 | 2021 | |
| Cook Medical LLC | $16.04 | 2023 | Bakri |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynn Westphal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.